Still, whereas a number of studies have demonstrated that DACH1 profoundly improves the prognosis of cancer patients as a tumor suppressor, a few studies have also observed an oncogenic role of DACH1 in endometrial cancer and mixed lineage leukemia (MLL) [2, 24, 71]. This evidence concerns the gene DACH1 and leukemia.